HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance

HIV大分子相互作用及其对病毒耐药性进化的影响

基本信息

  • 批准号:
    8731926
  • 负责人:
  • 金额:
    $ 400.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2017-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We have formed the HIVE Center to characterize at the atomic level the structural and dynamic relationships between interacting macromolecules in the HIV life cycle. We will focus on interactions of the major HIV enzymes with their partners and effectors since they encompass key processes in the viral life cycle and as existing drug targets provide a rich base of structural, biological and evolutionary data that will serve to inform our goals. We will explore resistance evolution in HIV as an opportune platform upon which to characterize the dynamic relationships between interacting macromolecular structures at the atomic level. The HIVE Center comprises a group of investigators with considerable expertise in HIV crystallography, virology, molecular biology, synthetic chemistry and computational biology. We will study the mechanistic implications of viral macromolecular interactions and dynamics and its broader impacts of the evolution of drug resistance. The goals of this center are to answer the following fundamental questions with our studies: 1. How do structures of the HIV polyprotein precursors direct assembly, maturation, and replication? 2. What novel HIV-Host interactions drive DNA replication and integration? 3. How does dynamics impact viral fitness and how can it be exploited for therapeutic targeting? 4. What are the structural and dynamic consequences of resistance mutations in the HIV life cycle, and how? In order to carry out these studies we will develop, improve and apply the following Technical Methods for: 1. Efficient expression, crystallization, and atomic level structure determination of HIV polyprotein and nucleic acid complexes. 2. Determination and characterization of novel binding sites and their impact on the dynamic and evolutionary properties of HIV protein complexes. 3. Computational methods to characterize the interactions, dynamics and evolution of HIV protein complexes at multiple spatial and temporal scales. Our approach is significant both for the promise of new structural insights into the interdependence of viral mechanisms, but also for the direct potential for new drug design methodologies and therapeutic strategies.
描述(由申请人提供):我们成立了HIVE中心,在原子水平上表征HIV生命周期中相互作用的大分子之间的结构和动态关系。我们将重点关注主要的HIV酶与它们的伙伴和效应物的相互作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARTHUR J. OLSON其他文献

ARTHUR J. OLSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARTHUR J. OLSON', 18)}}的其他基金

Discovery and use of chemical probes through SuFEx chemistry, computational design and predictive modeling
通过 SuFEx 化学、计算设计和预测建模发现和使用化学探针
  • 批准号:
    10242910
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
Discovery and use of chemical probes through SuFEx chemistry, computational design and predictive modeling
通过 SuFEx 化学、计算设计和预测建模发现和使用化学探针
  • 批准号:
    10363027
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
  • 批准号:
    8537483
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
Core
  • 批准号:
    8497063
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
  • 批准号:
    8411426
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
  • 批准号:
    8641747
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
  • 批准号:
    8920604
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
SMALL MOLECULES REGULATING PROTEIN-PROTEIN INTERACTIONS IN CANCER
调节癌症中蛋白质-蛋白质相互作用的小分子
  • 批准号:
    8362797
  • 财政年份:
    2011
  • 资助金额:
    $ 400.67万
  • 项目类别:
PRESERVING VISION IN INHERITED AND AGE-RELATED RETINAL DEGENERATIONS
保护遗传性和年龄相关性视网膜变性患者的视力
  • 批准号:
    8362798
  • 财政年份:
    2011
  • 资助金额:
    $ 400.67万
  • 项目类别:
Resistance Driven Structural Design for HIV Therapies
HIV 疗法的阻力驱动结构设计
  • 批准号:
    7931497
  • 财政年份:
    2009
  • 资助金额:
    $ 400.67万
  • 项目类别:

相似国自然基金

Galaxy Analytical Modeling Evolution (GAME) and cosmological hydrodynamic simulations.
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
Understanding structural evolution of galaxies with machine learning
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
The formation and evolution of planetary systems in dense star clusters
  • 批准号:
    11043007
  • 批准年份:
    2010
  • 资助金额:
    10.0 万元
  • 项目类别:
    专项基金项目
Improving modelling of compact binary evolution.
  • 批准号:
    10903001
  • 批准年份:
    2009
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Interdependency of Drug Resistance Evolution and Drug Design: HIV-1 Protease
耐药性进化与药物设计的相互依赖性:HIV-1 蛋白酶
  • 批准号:
    8912508
  • 财政年份:
    2014
  • 资助金额:
    $ 400.67万
  • 项目类别:
The Interdependency of Drug Resistance Evolution and Drug Design: HIV-1 Protease
耐药性进化与药物设计的相互依赖性:HIV-1 蛋白酶
  • 批准号:
    8789525
  • 财政年份:
    2014
  • 资助金额:
    $ 400.67万
  • 项目类别:
The Interdependency of Drug Resistance Evolution and Drug Design: HIV-1 Protease
耐药性进化与药物设计的相互依赖性:HIV-1 蛋白酶
  • 批准号:
    9321824
  • 财政年份:
    2014
  • 资助金额:
    $ 400.67万
  • 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
  • 批准号:
    8537483
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
  • 批准号:
    8411426
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
  • 批准号:
    8641747
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
  • 批准号:
    8920604
  • 财政年份:
    2012
  • 资助金额:
    $ 400.67万
  • 项目类别:
ORIGIN AND EVOLUTION OF HIV-1 DRUG RESISTANCE
HIV-1 耐药性的起源和演变
  • 批准号:
    8357636
  • 财政年份:
    2011
  • 资助金额:
    $ 400.67万
  • 项目类别:
Origin and Evolution of HIV-1 Drug Resistance in the RT-SHIVmne Macaque Model
RT-SHIVmne 猕猴模型中 HIV-1 耐药性的起源和演变
  • 批准号:
    8206592
  • 财政年份:
    2010
  • 资助金额:
    $ 400.67万
  • 项目类别:
Origin and Evolution of HIV-1 Drug Resistance in the RT-SHIVmne Macaque Model
RT-SHIVmne 猕猴模型中 HIV-1 耐药性的起源和演变
  • 批准号:
    8415961
  • 财政年份:
    2010
  • 资助金额:
    $ 400.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了